NCT03246113 Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma Status TERMINATED Phase PHASE1
NCT03232424 NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1
NCT03224104 Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma. Status COMPLETED Phase PHASE1
NCT03213002 Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM Status RECRUITING Phase PHASE1/PHASE2
NCT03204032 A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor Status UNKNOWN Phase PHASE2
NCT03197506 Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03189706 Study of Chemoimmunotherapy for High-Risk Neuroblastoma Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT03180502 Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03174197 Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT03168919 Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma Status TERMINATED Phase NA
NCT03150810 Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT03139916 Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE2
NCT03139331 PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma Status COMPLETED Phase PHASE1
NCT03137888 Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma Status COMPLETED Phase PHASE2
NCT03119064 BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT03018288 Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM) Status TERMINATED Phase PHASE2
NCT03011671 Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03008148 Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM Status UNKNOWN Phase PHASE2/PHASE3